[1] |
WANG Jiaqing, WANG Qi, LIU Tongtong, ZHANG Dongjie, CHEN Qi, MEI Shenghui, NING Xiao.
Determination of Linezolid Concentrations in Plasma with HPLC-MS/MS Method
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 377-380.
|
[2] |
LAN Xiaoqian, GUO Wei.
Trough Steady-State Concentration/Dose Ratio and Contributors to Adverse Drug Reactions of Sulpiride
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 420-423.
|
[3] |
HOU Tiantian, WANG Xudong, YANG Ping, ZHOU Pengbo, QIN Chao, HUANG Ying, WANG Ailing, GENG Xingchao, ZHOU Xiaobing, LIU Defang.
Biodistribution of Therapeutic DNA Vaccines in Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 58-66.
|
[4] |
YU Wenlu, ZHANG Hong.
Research Progress in Applications of Strychnine Semen in Orthopedics and Traumatology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 116-120.
|
[5] |
CAO Yin, ZHOU Xuan, DAI Biao, DENG Yiyun, YAN Chunyu, SHAN Feng, XIA Qingrong, LIANG Jun.
A UPLC-MS/MS method for determination of human serum trazodone concentration and its clinical individualized medications
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 991-997.
|
[6] |
LIU Yi, LIU Xiaoqiang, YAO Xiao, LI Xuantang, GUO Xianhui, GENG Ying, PEI Yusheng.
Clinical compatibility of bromhexine injectable preparations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 884-887.
|
[7] |
XIE Zhiqiang, YUAN Jiqiao, LI Jialin, LIU Zhengyue, WANG Manyuan.
Therapeutic effect and immune mechanism of artemisia annua L. ointment on mouse eczema models
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 617-624.
|
[8] |
YU Xin, GONG Leilei, YAO Weijie, YUAN Sisi, FENG Xin.
Chinese patent medicines for recurrent spontaneous abortion: a scoping review of clinical evidence
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 361-365.
|
[9] |
LI Shuran, GUO Shanshan, BAO Lei, SUN Jing, ZHAO Ronghua, BAO Yanyan, GENG Zihan, ZHANG Yu, CAO Shan, LYU Yaozhong, WANG Zhenzhong, CUI Xiaolan, WANG Hongmei.
Therapeutic effect of Foshao granules in mice with functional abdominal pain
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 269-272.
|
[10] |
DU Jianmin, ZHANG Chenning, ZHANG Xinghai, ZHANG Wenyu, ZHAO Hengli, WEN Qing.
Mechanism of Xinmaitong Tablets against Resistant Hypertension Based on Untargeted Proteomic Analysis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1270-1275.
|
[11] |
WANG Hengxin, DUN Wenliang, HU Jinwen, LI Qing, ZHAO Zeyu, LUO Tianjiong.
Identification and clinical characteristics of potential suspicious traditional Chinese medicines in traditional Chinese medicine-related liver injury
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1130-1136.
|
[12] |
LI Xingren, SHEN Aizong, SU Dan.
Evaluation of the rationality of proton pump inhibitors in preventing perioperative stress related mucosal disease in biliary and pancreatic surgery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1022-1026.
|
[13] |
DONG Hanshuo, SUN Li, ZHAO Xiaoxiao, WANG Lianxin, YU Xiaokang, XIE Yanming.
Clinical characteristics and drug combination analysis of elemene injectable emulsion in the elderly in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 845-850.
|
[14] |
ZHANG Lei, LI Yuanyuan, XIE Yanming, WANG Lianxin, YANG Xiaochen.
The medication of Breviscapine injection in the treatment of angina pectoris in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 857-861.
|
[15] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|